	US 12,453,362 B2
	Astringency reducing agent
Eri Ozeki, Oyama (JP); Akihiro Takamura, Haga-gun (JP); Kohjiro Hashizume, Utsunomiya (JP); Yoriko Ooki, Bunkyo-ku (JP); and Tomoya Takahashi, Chiba (JP)
Assigned to KAO CORPORATION, Tokyo (JP)
Appl. No. 17/998,953
Filed by KAO CORPORATION, Tokyo (JP)
PCT Filed May 28, 2021, PCT No. PCT/JP2021/020386 § 371(c)(1), (2) Date Nov. 16, 2022, PCT Pub. No. WO2021/246308, PCT Pub. Date Dec. 9, 2021.
Claims priority of application No. 2020-095597 (JP), filed on Jun. 1, 2020.
Prior Publication US 2023/0225382 A1, Jul. 20, 2023
Int. Cl. A23L 27/00 (2016.01); A23L 2/56 (2006.01)

CPC A23L 27/84 (2016.08) [A23L 2/56 (2013.01)]

9 Claims

1. An astringency reducing agent, comprising

an arabinogalactan which has a molecular weight of from 10,000 to 1,000,000 and a ratio of 1,3-bound galactose to total galactose of 18 mol % to 60 mol %, as an active ingredient; and

at least one carrier for formulation, selected from the group consisting of an excipient, a binder, an extender, and a diluent, wherein

the astringency reducing agent is substantially free of proteins, lipids, and carbohydrates other than the arabinogalactan.